Daewoong Pharmaceutical Operates Global Talent Development Program in Indonesia

[Asia Economy Reporter Lee Chun-hee] Daewoong Pharmaceutical announced on the 8th that it started the 3rd course of the ‘Daewoong Global DDS Education Program,’ involving 13 Indonesian pharmacy master's and doctoral students, on the 1st of this month.

This program selects Indonesian master's and doctoral students to nurture global talent in the pharmaceutical field. It is conducted over a total of 17 weeks from June 1 to July 29 at Daewoong Pharmaceutical’s Yongin Research Center. The program was initiated to establish a credit-linked education and research cooperation network between Daewoong Pharmaceutical’s research center and Indonesian pharmacy schools, and to create a global open collaboration training platform for cultivating experts in the pharmaceutical sector.

The 13 Indonesian master's and doctoral students, selected through a competitive process with a ratio of 5 to 1, are divided into chemical and bio fields and are engaged in the actual pharmaceutical formulation technology development process at Daewoong Pharmaceutical’s Yongin R&D Center. During the practical training period, they carry out projects under the mentoring of Daewoong Pharmaceutical researchers and receive broad and specialized learning opportunities such as monthly expert lectures by top domestic formulation technology and pharmaceutical development specialists, and GMP practice at pharmaceutical factories. Students who achieve excellent results are also given opportunities to join Daewoong Pharmaceutical’s research, quality, and production departments in both Korea and Indonesia.

For this program, Daewoong Pharmaceutical conducted COVID-19 diagnostic tests before deploying students to practical training at the Yongin Research Center and is thoroughly managing its own quarantine measures. Considering the religious characteristics of trainees from Islamic cultural backgrounds, meals excluding pork are provided, and during Ramadan, meal times and prayer spaces will be offered.

Kut Raihana, a doctoral student in pharmaceutics at Bandung Institute of Technology in Indonesia, said, “I am very pleased to have the opportunity to learn at Daewoong Pharmaceutical, a leading Korean pharmaceutical company and global healthcare group,” adding, “Through this program, I want to gain experience and knowledge in pharmaceutical research and development applying the latest formulation technologies and further contribute to improving the quality of life of my fellow countrymen.”

Kim Kwan-young, Head of the New Product Center at Daewoong Pharmaceutical, said, “It is meaningful to be able to conduct a program that nurtures the next-generation leaders who will lead the Indonesian pharmaceutical and bio industries.”

This content was produced with the assistance of AI translation services.